Orlistat Hexal

Orlistat, the active ingredient in Orlistat Hexal, is a lipase inhibitor presented as a unknown/unknown for oral use. It treats obesity and overweight in adults when used with a reduced‑calorie diet and lifestyle changes.

GNH USA supplies Orlistat Hexal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Orlistat Hexal is a lipase‑inhibiting anti‑obesity agent that works within the gastrointestinal tract to limit fat absorption. - Obesity: helps reduce body weight when combined with diet modification. - Overweight: assists in modest weight loss as an adjunct to lifestyle changes. - Weight‑related metabolic risk: may improve waist‑circumference and lipid profiles when used as part of a comprehensive weight‑management program.

Orlistat may produce gastrointestinal‑related adverse reactions that are generally mild and reversible.

Common Side Effects: - Oily spotting of the stool. - Increased frequency of bowel movements. - Fecal urgency. - Flatulence with discharge. - Fatty or oily stool. - Abdominal cramping.

Serious or Rare Side Effects: - Oily‑type dermatitis of the perianal area. - Severe abdominal pain. - Liver enzyme elevations. - Acute pancreatitis. - Allergic reactions such as urticaria, angio‑edema. - Persistent, unexplained gastrointestinal bleeding.

Before ​        ​       ​    ...

Major ...